(esmo), a leading global full-service systems integrator, developer, and supplier of innovative and advanced automation ...

The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.

There were no treatment-related deaths. Results are consistent with the data reported on the first 19 patients in Study 303 at ESMO in September. Published first on TheFly – the ultimate source for ...

We recently presented encouraging efficacy and safety data at ESMO on NUC-7738 plus pembrolizumab in patients with metastatic melanoma who were refractory or resistant to PD-1 inhibitors. We are ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good day, everyone, and welcome to today’s BioAtla Third Quarter 2024 Earnings Call. [Operator Instructions] It is now my pleasure to turn ...

The largest ever clinical trial of T cell therapy (a type of cell-based immunotherapy) for solid tumours has been completed. Led by a Singapore clinician-investigator, the global, international, ...

Fecal microbiota transplantation has significantly improved progression-free survival in patients with metastatic renal cell ...

Lenvatinib plus pembrolizumab has improved survival rates for patients with intermediate-stage hepatocellular cancer, ...

On Nov. 7, Insulet reported better-than-expected third-quarter financial results. “We continue to achieve significant milestones and robust revenue growth,” said Jim Hollingshead, President and Chief ...

Voters on Tuesday will choose the next president of the United States. Every vote matters, but the electoral results in a handful of key swing states will play major roles in determining the ...

On Nov. 5, voters across the U.S. cast final ballots that will set the direction of the country, state and local municipalities for years to come. Heading into Election Day, Democrat Kamala Harris ...